Mechanism
Progesterone is metabolized to allopregnanolone, a potent GABA-A receptor positive allosteric modulator — functionally similar to benzodiazepines and alcohol in its calming effects. In the late luteal phase, progesterone (and therefore allopregnanolone) drops sharply. In women with PMDD, the brain's GABA-A receptors undergo paradoxical changes during this withdrawal — they become less responsive to allopregnanolone, creating a withdrawal-like state even from physiological levels. The result: anxiety, irritability, crying episodes, anger, and sometimes suicidal ideation — all occurring predictably in the 7–14 days before menstruation and resolving completely within 48–72 hours of period onset.
Signs & Symptoms
- Severe mood changes appearing 7–14 days before period — irritability, anger, anxiety, depression
- Symptoms completely resolving within 2–3 days of period starting
- Functional impairment — symptoms affect work, relationships, training capacity
- Cyclical pattern confirmed over at least 3 consecutive cycles
- Feeling "not like myself" premenstrually — loss of sense of self
- Sensitivity to rejection, criticism, and perceived social failures dramatically increases
- In severe cases: suicidal ideation that also resolves with period onset
Stages
Prevention
- Magnesium glycinate 400–600mg/day starting at ovulation (Day 14) — supports GABA function
- Vitamin B6 100mg/day — cofactor for serotonin synthesis, reduces PMS severity in trials
- Reduce caffeine and alcohol during luteal phase — both worsen GABA function disruption
- Regular moderate exercise during luteal phase — endorphin and GABA-ergic mechanism of benefit
- Consistent sleep schedule — sleep deprivation dramatically worsens neurosteroid sensitivity
Management Protocol
- Track symptoms for 3 cycles using PMDD daily rating form — document severity and timing for medical consultation
- Magnesium 400–600mg + B6 100mg + Vitamin D3 2000 IU from ovulation to period
- Luteal-phase SSRIs (prescribed by psychiatrist) — fluoxetine, sertraline taken only Days 14–28 is highly effective and evidence-backed for PMDD
- GnRH agonist therapy — medical hormonal suppression for severe PMDD (only under specialist)
- Cognitive behavioral therapy specifically for PMDD — strong evidence base
- Avoid starting compound use in the luteal phase — any HPO disruption worsens PMDD
Risk by Compound
| Compound | Risk Level | Notes |
|---|---|---|
| Any hormonal compound | Worsen | HPO disruption from any compound can intensify PMDD via further progesterone dysregulation. |
| Magnesium Glycinate | Beneficial | 400–600mg from ovulation. Best single supplement for PMDD management. |
| Luteal-phase SSRIs | Beneficial (Rx) | Fluoxetine/Sertraline Days 14–28. Most evidence-backed pharmacological treatment. Requires psychiatrist. |
PMDD is not weakness and it is not attitude. It is a neurological response to a predictable hormonal event, and it is treatable. If every month you lose 1–2 weeks of your life to mood episodes that disappear the moment your period arrives — that is not something to white-knuckle through. Luteal-phase SSRIs have a better response rate for PMDD than for general depression. Tell your psychiatrist or gynecologist about the cyclical pattern specifically.